CD8A and nonpapillary renal cell carcinoma: Together, these results indicated that BMRCCs were enriched with infiltrated T cell subtypes with distinct status from the primary ccRCC, and treatment might affect the trajectory path of CD8-Tem cells by activating TFs for T cell activation in the BMRCC.